Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010

Article ID	Journal	Published Year	Pages	File Type
10966562	Vaccine	2013	11 Pages	PDF

Abstract

âº From 2007 to 2010, African countries implemented YF preventive vaccination campaigns. âº 38 million people were vaccinated against YF and 164 serious adverse events observed. âº Few serious adverse events results from YF vaccine. âº Our results reinforce the generally accepted safety profile of YF vaccine. âº The continued use of YF vaccine during preventive vaccination campaigns is supported.

Keywords

RKI AEFI IFA YFV RT-PCR ADEM Pharmacovigilance NEC Immunofluorescent antibody acute disseminated encephalomyelitis Vaccine safety Yellow fever Enzyme-linked immunosorbent assay ELISA Adverse event following immunization World Health Organization adverse event CSF Cerebrospinal fluid Yellow fever vaccine reverse transcription polymerase chain reaction WHO

Related Topics

Life Sciences Immunology and Microbiology Immunology

Preview

Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010

Authors

J.G. Breugelmans, R.F. Lewis, E. Agbenu, O. Veit, D. Jackson, C. Domingo, M. Böthe, W. Perea, M. Niedrig, B.D. Gessner, S. Yactayo, on behalf of the YF AEFI group on behalf of the YF AEFI group,